As of Apr 17
| -0.68 / -3.96%|
The 5 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 22.00, with a high estimate of 33.00 and a low estimate of 20.00. The median estimate represents a +33.41% increase from the last price of 16.49.
The current consensus among 5 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.